150 related articles for article (PubMed ID: 32804104)
1. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
2. The central diabetes insipidus associated with septo-optic dysplasia (de Morsier syndrome).
Hetman M; Fułek M; Zajączkowska K; Żarczyńska A; Łagosz P; Barg E
Pediatr Endocrinol Diabetes Metab; 2018; 24(4):197-203. PubMed ID: 30963758
[TBL] [Abstract][Full Text] [Related]
3. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
4. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
[TBL] [Abstract][Full Text] [Related]
5. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
6. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
Biset A; Claris O
Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
[TBL] [Abstract][Full Text] [Related]
8. Transient polyuria related to central diabetes insipidus caused by lymphocytic infundibulo-neurohypophysitis in a patient treated for Graves' disease.
Yamazaki M; Sato A; Nishio S; Uehara T; Komatsu M
Intern Med; 2010; 49(17):1885-90. PubMed ID: 20823651
[TBL] [Abstract][Full Text] [Related]
9. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
10. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
12. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics.
Rivkees SA; Dunbar N; Wilson TA
J Pediatr Endocrinol Metab; 2007 Apr; 20(4):459-69. PubMed ID: 17550208
[TBL] [Abstract][Full Text] [Related]
13. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
14. Diabetes insipidus and pregnancy.
Chanson P; Salenave S
Ann Endocrinol (Paris); 2016 Jun; 77(2):135-8. PubMed ID: 27172867
[TBL] [Abstract][Full Text] [Related]
15. [Central diabetes insipidus: diagnosis and management].
Ballan BK; Hernandez A; Rodriguez EG; Meyer P
Rev Med Suisse; 2012 Nov; 8(362):2158, 2160-4. PubMed ID: 23240316
[TBL] [Abstract][Full Text] [Related]
16. Central diabetes insipidus: alert for dehydration in very low birth weight infants during the neonatal period. A case report.
Ferlin ML; Sales DS; Celini FP; Martinelli Junior CE
Sao Paulo Med J; 2015 Feb; 133(1):60-3. PubMed ID: 25271879
[TBL] [Abstract][Full Text] [Related]
17. Infection with SARS-CoV-2 may alter the half-life of desmopressin (DDAVP) in patients with central diabetes insipidus.
Dubinski I; Bechtold-Dalla Pozza S; Schmidt H
J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1544-1546. PubMed ID: 36240057
[TBL] [Abstract][Full Text] [Related]
18. Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion.
Cristiano EA; Harris A; Grdinovac K
AACE Clin Case Rep; 2022; 8(1):8-10. PubMed ID: 35097193
[TBL] [Abstract][Full Text] [Related]
19. Profound hypernatremia due to central diabetes insipidus.
Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
[TBL] [Abstract][Full Text] [Related]
20. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
